Clinical Trial: A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma

U.S., Aug. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07098403) titled 'A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma' on July 25.

Brief Summary: This study is a phase III study of SHR-1905 in subjects with severe uncontrolled asthma. The purpose of the study is to evaluate efficacy and safety of SHR-1905 in subjects with severe uncontrolled asthma.

Study Start Date: Aug., 2025

Study Type: INTERVENTIONAL

Condition: Asthma

Intervention: DRUG: SHR-1905 Injection

SHR-1905 injection.

DRUG: SHR-1905 Placebo Injection

SHR-1905 placebo Injection.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd

Published by HT Digital Content Services with p...